BR9708648A - Muteina de il-6 - Google Patents

Muteina de il-6

Info

Publication number
BR9708648A
BR9708648A BR9708648A BR9708648A BR9708648A BR 9708648 A BR9708648 A BR 9708648A BR 9708648 A BR9708648 A BR 9708648A BR 9708648 A BR9708648 A BR 9708648A BR 9708648 A BR9708648 A BR 9708648A
Authority
BR
Brazil
Prior art keywords
mutein
diseases
auotoimmune
plasmocytoma
neoplastic
Prior art date
Application number
BR9708648A
Other languages
English (en)
Other versions
BR9708648B1 (pt
Inventor
March Ehlers
Stefan Rose-John
Joachim Grotzinger
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR9708648A publication Critical patent/BR9708648A/pt
Publication of BR9708648B1 publication Critical patent/BR9708648B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Amplifiers (AREA)
  • Details Of Television Scanning (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
BRPI9708648-7A 1996-04-09 1997-04-08 polipeptìdeo, molécula de dna, vetor, processo para a produção do polipeptìdeo, e composição farmacêutica. BR9708648B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NLEP96/1506 1996-04-09
CN96180247A CN1131309C (zh) 1996-04-09 1996-04-09 白细胞介素－6突变蛋白
PCT/EP1996/001506 WO1997038103A1 (en) 1996-04-09 1996-04-09 Il-6 mutein
CA002251355A CA2251355C (en) 1996-04-09 1996-04-09 Il-6 mutein
PCT/EP1997/001736 WO1997038104A1 (en) 1996-04-09 1997-04-08 Il-6 mutein

Publications (2)

Publication Number Publication Date
BR9708648A true BR9708648A (pt) 1999-08-03
BR9708648B1 BR9708648B1 (pt) 2011-02-08

Family

ID=27170853

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9708648-7A BR9708648B1 (pt) 1996-04-09 1997-04-08 polipeptìdeo, molécula de dna, vetor, processo para a produção do polipeptìdeo, e composição farmacêutica.

Country Status (19)

Country Link
US (1) US6280975B1 (pt)
EP (1) EP0907737B1 (pt)
JP (1) JP4189866B2 (pt)
CN (1) CN1131309C (pt)
AT (1) ATE291087T1 (pt)
AU (1) AU728267B2 (pt)
BR (1) BR9708648B1 (pt)
CA (1) CA2251355C (pt)
DE (1) DE69634497T2 (pt)
DK (1) DK0907737T3 (pt)
EA (1) EA000852B1 (pt)
ES (1) ES2238690T3 (pt)
FI (1) FI982198A (pt)
HK (1) HK1019770A1 (pt)
IL (1) IL126484A0 (pt)
NO (1) NO322479B1 (pt)
PT (1) PT907737E (pt)
UA (1) UA72426C2 (pt)
WO (2) WO1997038103A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297083B6 (cs) * 1998-03-17 2006-09-13 Chugai Seiyaku Kabushiki Kaisha Cinidlo pro prevenci a lécbu zánetlivého onemocnení streva obsahující aktivní slozku antagonistu IL-6
KR20060119412A (ko) * 2005-05-20 2006-11-24 아주대학교산학협력단 ＩＬ-6 발현 억제를 위한 ｓｉＲＮＡ 및 이를 함유하는조성물
US8522915B2 (en) * 2007-12-19 2013-09-03 Westerngeco L.L.C. Method and system for selecting parameters of a seismic source array
CN102101885B (zh) * 2010-09-01 2013-06-05 南京发士达生物科技有限公司 低诱导抑制性t细胞的人白细胞介素ⅱ突变体及其用途

Also Published As

Publication number Publication date
EA000852B1 (ru) 2000-06-26
EA199800914A1 (ru) 1999-04-29
JP2000508164A (ja) 2000-07-04
CN1216063A (zh) 1999-05-05
HK1019770A1 (en) 2000-02-25
ES2238690T3 (es) 2005-09-01
JP4189866B2 (ja) 2008-12-03
ATE291087T1 (de) 2005-04-15
NO984697L (no) 1998-10-08
WO1997038104A1 (en) 1997-10-16
CA2251355A1 (en) 1997-10-16
DE69634497T2 (de) 2006-01-26
CN1131309C (zh) 2003-12-17
US6280975B1 (en) 2001-08-28
EP0907737A1 (en) 1999-04-14
DK0907737T3 (da) 2005-06-27
IL126484A0 (en) 1999-08-17
NO322479B1 (no) 2006-10-09
NO984697D0 (no) 1998-10-08
FI982198A0 (fi) 1998-10-09
AU728267B2 (en) 2001-01-04
BR9708648B1 (pt) 2011-02-08
CA2251355C (en) 2009-06-09
FI982198A (fi) 1998-10-09
PT907737E (pt) 2005-05-31
DE69634497D1 (de) 2005-04-21
UA72426C2 (en) 2005-03-15
EP0907737B1 (en) 2005-03-16
AU5686496A (en) 1997-10-29
WO1997038103A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
PL371428A1 (en) Substituted indolizine-like compounds and methods of use
EA200200806A1 (ru) Предупреждение потери и восстановление костной массы некоторыми агонистами простагландина
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
DK1309589T3 (da) Ureaforbindelser og anvendelsesfremgangsmåder
SE9802729D0 (sv) Novel Compounds
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
EP1423414A4 (en) NEW DEPSIPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF
DE69814109D1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
BR9708648A (pt) Muteina de il-6
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DE69819922D1 (de) 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten
ID24561A (id) Pemakaian protein matriks oligomerik kartilaj untuk mengobati artritis rematoid
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.

Legal Events

Date Code Title Description
TE Change of address
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO SA (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/02/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: MERCK SERONO S.A. (CH)

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.68486/2013 ORIGEM: JUIZO DA 25A VARA FEDERAL DE SAO PAULO PROCESSO NO 0017574-93.2013.4.03.6100 ACAO DE NULIDADE DE PATENTE AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: BAYER SAS, CENTELION E CENTELION S.A., CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, MERCK SERONO S.A. E SAMJIN PHARMACEUTICAL CO. LTD.

B22E Other requirements [chapter 22.5 patent gazette]

Free format text: PARA QUE O PROTOCOLO ELETRONICO NO 860140003718/WBRJ DE 13.01.2014 SEJA CONHECIDO, O PROCURADOR DEVERA APRESENTAR DOCUMENTO DE PROCURACAO OUTORGADO PELO DEPOSITANTE, NO ORIGINAL OU COPIA AUTENTICADA, DANDO-LHE PODERES PARA A RENUNCIA DA PATENTE.

B21B Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties

Free format text: HOMOLOGADA A RENUNCIA DA PATENTE, SOLICITADA ATRAVES DO PROTOCOLO ELETRONICO NO WBRJ 860140003718 DE 13/01/2014.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.068486/2013 SECAO JUDICIARIA DE SAO PAULO - 25A VARA FEDERAL CIVEL DE SAO PAULO PROCESSO NO0017574-93.2013.403.6100 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: BAYER SAS, CENTELION, CENTELION S.A, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, MERCK SERONO S.A E SAMJIN PHARMACEUTICAL CO. LTDA DECISAO: RECONHECO A PERDA DO OBJETO DA ACAO EM RELACAO AS PATENTES PI 9510567-0 E PI 9708648-7 DA EMPRESA MERCK SERONO S.A., E JULGO EXTINTO O PEDIDO SEM RESOLUCAO DO MERITO, NOS TERMOS DO ARTIGO 485, VI DO CODIGO DE PROCESSO CIVIL.